Home › Funds › Candriam S.C.A. › XYL

Candriam S.C.A. position in XYL

XYLEM INC · Industrials

Candriam S.C.A. reported holding 875,838 shares of XYL (XYLEM INC) in its Q3 2026 13F filing — a position valued at US$89.0M, representing 0.40% of its reported portfolio and ranking #47 among its reported holdings. Candriam S.C.A. has disclosed XYL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)875.84K sh
Reported value held$89.02M
Portfolio Weight0.40%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Candriam S.C.A.'s XYL position evolved

Candriam S.C.A. first disclosed a stake in XYL in Q3 2023 at 201,013 shares (US$18.2M). The position peaked in Q1 2026 at 974,871 shares, worth US$116.5M. Across 13 filings, Candriam S.C.A. increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 875,838 shares valued at US$89.0M — a reduction of -106,420 shares quarter over quarter.. Notable position changes include a 78% increase in Q3 2024 (shares fell 14% over the following quarter), a 34% trim in Q1 2025 (shares rose 8% over the following quarter), a 37% increase in Q4 2025 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 201.01K $18.21M New
Q4 2023 263.75K $30.16M Add
Q1 2024 275.16K $35.56M Add
Q2 2024 304.16K $41.25M Add
Q3 2024 541.03K $73.05M Add
Q4 2024 668.68K $77.58M Add
Q1 2025 440.71K $52.65M Reduce
Q2 2025 498.04K $64.43M Add
Q3 2025 555.60K $81.95M Add
Q4 2025 761.42K $103.69M Add
Q1 2026 974.87K $116.50M Add
Q2 2026 982.26K $116.00M Add
Q3 2026 875.84K $89.02M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XYL and 13F data

XYL (XYLEM INC) is a Industrials company. 20 other funds we track also report a position in XYL — the largest reported positions include Impax Asset Management Group plc (US$478.2M), HSBC HOLDINGS PLC (US$319.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XYL

All XYL fund holders →

FAQ

How long has Candriam S.C.A. held XYL?

Candriam S.C.A. has disclosed XYL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Candriam S.C.A.'s current position in XYL?

As of Q3 2026, Candriam S.C.A. holds 875.84K shares of XYL (XYLEM INC), valued at $89.02M, representing 0.40% of its reported portfolio and ranking #47.

Has Candriam S.C.A. been buying or selling XYL?

In the latest 13F filing (Q3 2026), Candriam S.C.A. reduced its position in XYL. The position peaked in Q1 2026 at 974.87K shares.

Which other funds hold XYL?

Other major institutional holders of XYL include Impax Asset Management Group plc, HSBC HOLDINGS PLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.